Medical device recalls

Cytocell Ltd. recalls TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequenc…

Recall date
February 4, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0814-2022
FDA classification
Class III
Brand / firm
Cytocell Ltd.
Sold / distributed
MN

Why it was recalled

May show unexpected locus specific signals in addition to those at 14q32.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A

Get recall alerts

Free email alert whenever Cytocell Ltd. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Cytocell Ltd.